116 related articles for article (PubMed ID: 1949716)
21. Saline anti-Rh(D) and haemolytic disease of the newborn.
Hopkins DF
Vox Sang; 1969 Jan; 16(1):32-46. PubMed ID: 4974788
[No Abstract] [Full Text] [Related]
22. [Manner, formation of hazardous antibodies for pregnancy].
Aufeuvre JP
Soins Gynecol Obstet Pueric Pediatr; 1983; (27-28):7-10. PubMed ID: 6558884
[No Abstract] [Full Text] [Related]
23. ABO alloimmunisation after intravenous immunoglobulin infusion.
Potter M; Stockley R; Storry J; Slade R
Lancet; 1988 Apr; 1(8591):932-3. PubMed ID: 2895844
[No Abstract] [Full Text] [Related]
24. Destruction of IgG anti-A sensitized erythrocytes by mononuclear leucocytes from normal and ABO haemolytic disease affected infants.
Romano EL; Rossi Devivo ML; Soyano A; Linares J
Clin Exp Immunol; 1984 Feb; 55(2):451-8. PubMed ID: 6538121
[TBL] [Abstract][Full Text] [Related]
25. [Clinical picture and the course of infection in hemolytic disease of the newborn].
Maszkiewicz W; Koralewska J; Bokrzycka-Krysiak K; Kupiec G
Acta Haematol Pol; 1988; 19(1-2):99-103. PubMed ID: 3149119
[No Abstract] [Full Text] [Related]
26. Prevention of Rh-haemolytic disease.
Clarke CA
Br Med J; 1967 Oct; 4(5570):7-12. PubMed ID: 4167367
[No Abstract] [Full Text] [Related]
27. What is the optical serological analysis of haemolytic disease of the newborn due to ABO incompatibility?
Boorman KE; Bowley CC; Voak D; Fischer K; van Loghem JJ; Mollison PL; Rosenfeld RE; Tovey GH
Vox Sang; 1971 Feb; 20(2):182-92. PubMed ID: 5581704
[No Abstract] [Full Text] [Related]
28. A detailed serological study on the prediction and diagnosis of ABO haemolytic disease of the newborn (ABO HD).
Voak D; Bowley CC
Vox Sang; 1969 Nov; 17(5):321-48. PubMed ID: 5308005
[No Abstract] [Full Text] [Related]
29. Severe ABO haemolytic disease due to high titre IgG anti-B in an A2 mother.
Graham H; Morrison M; Casey E
Vox Sang; 1974; 27(4):363-8. PubMed ID: 4213379
[No Abstract] [Full Text] [Related]
30. [ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis].
Palleau S; Le Tourneau C; Jrad I; Andreux JP; Gouin I; Siguret V
Ann Biol Clin (Paris); 2004; 62(3):344-8. PubMed ID: 15217770
[TBL] [Abstract][Full Text] [Related]
31. Estimation of the number of females at risk of isoimmunization to the Rho (D) antigen in a sample of the population attended at the Instituto Mexicano del Seguro Social.
Zavala C; Velázquez-Ferrari MA; Navarrete C; Rosales-Corona J; Lisker R
Arch Invest Med (Mex); 1983; 14(2):199-206. PubMed ID: 6416200
[No Abstract] [Full Text] [Related]
32. Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
Brouwers HA; Overbeeke MA; Ouwehand WH; Keuning K; van Ertbruggen I; van Leeuwen EF; Stoop JW; Engelfriet CP
Br J Haematol; 1988 Dec; 70(4):465-9. PubMed ID: 3219297
[TBL] [Abstract][Full Text] [Related]
33. [Pathogenesis of ABO hemolytic disease of the newborn. Critical study].
Lewi S
Transfusion (Paris); 1966; 9(3):265-80. PubMed ID: 5969561
[No Abstract] [Full Text] [Related]
34. [Haemolytic disease of the newborn (fetus) (author's transl)].
Fischer K; Poschmann A
Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
[TBL] [Abstract][Full Text] [Related]
35. [Serology of ABO erythroblastosis].
Speiser P
Wien Med Wochenschr; 1966 Nov; 116(46):974-5. PubMed ID: 5989480
[No Abstract] [Full Text] [Related]
36. [Immunization mechanisms in the serological conflicts of ABO factors. 3. The 3d immunization mechanism in ABO conflict].
Skrzypulec Z
Ginekol Pol; 1969 Aug; 40(8):921-8. PubMed ID: 5820771
[No Abstract] [Full Text] [Related]
37. [A method of early diagnosis of hemolytic disease of the newborn].
Erina SA; Zheliabin AV; Gurevich PS; Osipov AI; Barsukov VS
Pediatriia; 1986 May; (5):31-3. PubMed ID: 3090514
[No Abstract] [Full Text] [Related]
38. [On the influence of maternal isoagglutinis on the ABO-incompatibility in newborn infants].
Schneeweiss B; Brandt N
Padiatr Grenzgeb; 1968; 7(4):225-33. PubMed ID: 5732839
[No Abstract] [Full Text] [Related]
39. [Platelet alloantigens and their clinical implications. Part 2: Clinical implications].
Mojaat N; Maamar M; Ben Hamed L; Moula A; Boukef K
Tunis Med; 2000 Feb; 78(2):78-81. PubMed ID: 10894041
[No Abstract] [Full Text] [Related]
40. RHESUS HAEMOLYTIC DISEASE OF THE NEWBORN AND THE ABO GROUPS.
MURRAY S; KNOX EG; WALKER W
Vox Sang; 1965; 10():6-31. PubMed ID: 14294360
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
